Search
for
Sort by
Research 211–240 of 655
- The Rare Occurrence of a Left Atrial Thrombus in a Dog
- Hormones and COVID-19
- Non-Contraceptive Benefits of Oral Hormonal Contraceptives
- COVID-19 and androgenic status: testosterone or dihydrotestosterone have a pivotal role?
- Recurrent implantation failure: A comprehensive summary from etiology to treatment
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Symptomatology of Long COVID Associated with Inherited and Acquired Thrombophilic Conditions: A Systematic Review
- Abstracts from the 4th Annual Student Medical Summit
- A narrative review of SARS-CoV-2 variants and long COVID
- Peripheral Arterial Disease: Diagnosis and Management
- Dermatologic care for lesbian, gay, bisexual, and transgender persons
- Peripheral Arterial Disease: Diagnosis and Management
- Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119)
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark
- Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population
- Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions
- Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Exploring novel management options for alopecia areata
- Transgender Competent Provider
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes
- Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- Gender Differences in Response to COVID-19 Infection and Vaccination